PATENT CLAIM ANALYSIS

Application Number: 15917926
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "186100"]

Abstract:
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.

Claim (Index 60):
The host cell of  claim 58 , wherein the recombinant influenza A virus comprises a mutant M gene comprising two stop codons at a position corresponding to nucleotides 786-791 of SEQ ID NO: 28, and a deletion of the nucleotides corresponding to nucleotides 792-842 of SEQ ID NO: 28.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.91429
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14128415', '15681613', '15125763', '13131733', '15538133']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8012519517900215
- 35 USC 102 Novelty (BERT): 0.6254914996638503
- Combined Prediction Score: 0.7836759065774044
- Mean Citation Score: 544.6996519999999
- Max Citation Score: 690.3398
- Similarity Product: 515.0959012282848

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test